SciSparc and Soroka Medical Center sign agreement for ASD drug trial
Middle East & Africa
GreenLight receives Rwanda FDA approval for Covid-19 mRNA vaccine trial
The Phase I/II clinical trial will evaluate the safety and immunogenicity of the vaccine.
SpliSense begins Phase I/II trial of SPL84 for cystic fibrosis
Nectin doses first subject in Phase I solid tumour immunotherapy trial
Enlivex announces first subject dosing in Phase I/II solid tumour trial
IQVIA and Clalit Health to launch prime site in Israel
Codagenix and SII begin subject dosing in Phase III Covid-19 vaccine trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
